
Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings
Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 累积投票制度实施细则 | 2025-08-26 | Chinese | |
| 关于2025年半年度募集资金存放与使用情况的专项报告 | 2025-08-26 | Chinese | |
| 关于聘任高级管理人员的公告 | 2025-08-26 | Chinese | |
| 第五届监事会第六次会议决议公告 | 2025-08-26 | Chinese | |
| 董事会薪酬与考核委员会工作条例 | 2025-08-26 | Chinese | |
| 子公司管理制度 | 2025-08-26 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39724040 | 累积投票制度实施细则 | 2025-08-26 | Chinese | ||
| 39724031 | 关于2025年半年度募集资金存放与使用情况的专项报告 | 2025-08-26 | Chinese | ||
| 39724026 | 关于聘任高级管理人员的公告 | 2025-08-26 | Chinese | ||
| 39724021 | 第五届监事会第六次会议决议公告 | 2025-08-26 | Chinese | ||
| 39724016 | 董事会薪酬与考核委员会工作条例 | 2025-08-26 | Chinese | ||
| 39724010 | 子公司管理制度 | 2025-08-26 | Chinese | ||
| 39724003 | 拓新药业集团股份有限公司章程 | 2025-08-26 | Chinese | ||
| 39723994 | 关于召开2025年第一次临时股东会的通知 | 2025-08-26 | Chinese | ||
| 39723984 | 关于职工代表监事辞职的公告 | 2025-08-22 | Chinese | ||
| 39723978 | 关于持股5%以上股东变更名称的公告 | 2025-07-25 | Chinese | ||
| 39723972 | 第五届董事会第六次会议决议公告 | 2025-07-16 | Chinese | ||
| 39723969 | 关于对外投资的公告 | 2025-07-16 | Chinese | ||
| 39723960 | 关于全资子公司胞磷胆碱原料药获得上市申请批准通知书的公告 | 2025-07-07 | Chinese | ||
| 39723951 | 关于公司控股股东、实际控制人之一致行动人减持计划实施时间届满的公告 | 2025-06-16 | Chinese | ||
| 39723941 | 关于子公司药品生产许可证变更的公告 | 2025-06-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Tuoxin Pharmaceutical Group Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56042/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56042 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56042 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56042 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56042}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tuoxin Pharmaceutical Group Co.,Ltd. (id: 56042)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.